Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v13-FR
Language English French
Date Updated 2023-06-02 2023-01-16
Drug Identification Number 02459906 02459906
Brand name ACETYLCYSTEINE SOLUTION USP ACETYLCYSTEINE SOLUTION USP
Common or Proper name ACETYLCYSTEINE SOLUTION USP ACETYLCYSTEINE SOLUTION USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients ACETYLCYSTEINE ACETYLCYSTEINE
Strength(s) 200MG 200MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION
Packaging size 30ML 30ML
ATC code R05CB R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-06 2022-10-06
Estimated end date 2023-01-20 2023-01-20
Actual end date 2023-01-20
Shortage status Resolved Actual shortage
Tier 3 Status No Yes
Company comments
Health Canada comments